SCHEMBL973116

SCHEMBL973116

CC(=O)Nc1ccc(C(=O)O)c(N)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.54
MYC P01106 1/20 0.53
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 3/20 0.51
HDAC1 Q13547 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
PYGL P06737 1/20 0.50
POLB P06746 2/20 0.49
HSD17B10 Q99714 2/20 0.47
HTT P42858 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NAPRT Q6XQN6 1/20 0.47
MPO P05164 1/20 0.47
NPC1 O15118 2/20 0.46
MAPT P10636 2/20 0.46
RAB9A P51151 2/20 0.46
KMT2A Q03164 2/20 0.46
HPGD P15428 1/20 0.46
MEN1 O00255 1/20 0.46
GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL258439 0.86 MYC (0.56) TDP1MYCALDH1A1KDM4EHDAC1
SCHEMBL2030008 0.86 MYC (0.56) TDP1MYCALDH1A1KDM4EHDAC1
SCHEMBL31597491 0.86 MYC (0.56) TDP1MYCALDH1A1KDM4EHDAC1
SCHEMBL11097889 0.85 MYC (0.47) TDP1MYCALDH1A1KDM4EHDAC1
SCHEMBL2500845 0.83 MYC (0.61) TDP1MYCALDH1A1KDM4ESMN1; SMN2
SCHEMBL11171029 0.83 SMN1; SMN2 (0.69) TDP1ALDH1A1KDM4EHDAC1SMN1; SMN2
SCHEMBL7904683 0.83 TDP1 (0.51) TDP1ALDH1A1KDM4EHDAC1SMN1; SMN2
SCHEMBL11778360 0.81 CYP3A4 (0.53) ALDH1A1KDM4ESMN1; SMN2PYGLPOLB
SCHEMBL7509092 0.81 TDP1 (0.60) TDP1ALDH1A1KDM4EHDAC1SMN1; SMN2
SCHEMBL30442658 0.81 TDP1 (0.60) TDP1ALDH1A1KDM4EHDAC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2017-11-02 US claimed
EP-3226907-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS AND MAKING AND USE THEREOF Kempharm, Inc. (US) 2017-10-11 EP claimed
EP-3223819-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE Kempharm, Inc. (US) 2017-10-04 EP claimed
US-20160168160-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2016-06-16 US claimed
WO-2016089951-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS AND MAKING AND USE THEREOF KEMPHARM, INC. (US) 2016-06-09 WO claimed
WO-2016086113-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE KEMPHARM, INC. (US) 2016-06-02 WO claimed
US-20160151352-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2016-06-02 US claimed
CN-104136031-A Benzoic acid, benzoic acid derivative and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and using thereof KEMPHARM INC 2014-11-05 CN claimed
EP-2771002-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF Kempharm, Inc. (US) 2014-09-03 EP claimed
US-20130150395-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF KEMPHARM, INC. (US) 2013-06-13 US claimed
WO-2013063204-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF KEMPHARM, INC. (US) 2013-05-02 WO claimed
US-20120142719-A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof ALTER DOMUS (US) LLC 2012-06-07 US claimed
CN-102480959-A Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof KEMPHARM INC 2012-05-30 CN claimed
EP-2448407-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF Kempharm, Inc. (US) 2012-05-09 EP claimed
US-20110002990-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2011-01-06 US claimed
US-12590065-B2 Levorphanol prodrugs and processes for making and using them ZEVRA THERAPEUTICS, INC. (US) 2026-03-31 US disclosed
US-20250032479-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM ZEVRA THERAPEUTICS INC (US) 2025-01-30 US disclosed
US-3989692-A PHTHALOCYANINE DYES, WOOL, SILK, POLYAMIDES, CELLULOSE BAYER AKTIENGESELLSCHAFT (DT) 1976-11-02 US disclosed
US-3980677-A Anthraquinone dyestuffs containing sulphonic acid groups BAYER AKTIENGESELLSCHAFT (DT) 1976-09-14 US disclosed
US-3971741-A DISPERSION PIGMENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250032479-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM OPRM1, OPRL1, OPRK1 TDP1 1221/4885MYC 4382/4885ALDH1A1 1276/4885
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 TDP1 828/4885MYC 4812/4885ALDH1A1 125/4885
US-20160151352-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 TDP1 828/4885MYC 4812/4885ALDH1A1 125/4885
US-12590065-B2 Levorphanol prodrugs and processes for making and using them SLC16A3, SLC16A8, SLC16A1 TDP1 1657/4885MYC 3674/4885ALDH1A1 716/4885
US-20160168160-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 TDP1 1697/4885MYC 4850/4885ALDH1A1 217/4885
US-20110002990-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF CYP2B6, CYP3A43, CYP2D6 TDP1 1526/4885MYC 2982/4885ALDH1A1 160/4885
US-20120142719-A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof CYP2B6, CYP3A43, CYP2D6 TDP1 1526/4885MYC 2982/4885ALDH1A1 160/4885
US-20130150395-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, CYP2D6 TDP1 1353/4885MYC 3705/4885ALDH1A1 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.